These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tea polyphenol carrier-enhanced dexamethasone nanomedicines for inflammation-targeted treatment of rheumatoid arthritis. Yi Z; Ran Y; Chen X; Tong Q; Ma L; Tan Y; Ma X; Li X J Mater Chem B; 2023 Dec; 11(48):11505-11518. PubMed ID: 38038124 [TBL] [Abstract][Full Text] [Related]
4. Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis. Yan F; Zhong Z; Wang Y; Feng Y; Mei Z; Li H; Chen X; Cai L; Li C J Nanobiotechnology; 2020 Aug; 18(1):115. PubMed ID: 32819405 [TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis. Wang Q; Jiang J; Chen W; Jiang H; Zhang Z; Sun X J Control Release; 2016 May; 230():64-72. PubMed ID: 27057749 [TBL] [Abstract][Full Text] [Related]
6. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1α/NF-κB cascade regulation of ROS scavenging and macrophage repolarization. Li Y; Liang Q; Zhou L; Cao Y; Yang J; Li J; Liu J; Bi J; Liu Y Acta Biomater; 2022 Oct; 152():406-424. PubMed ID: 36055613 [TBL] [Abstract][Full Text] [Related]
7. Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. Quan L; Zhang Y; Crielaard BJ; Dusad A; Lele SM; Rijcken CJF; Metselaar JM; Kostková H; Etrych T; Ulbrich K; Kiessling F; Mikuls TR; Hennink WE; Storm G; Lammers T; Wang D ACS Nano; 2014 Jan; 8(1):458-466. PubMed ID: 24341611 [TBL] [Abstract][Full Text] [Related]
8. Dually Enzyme- and Acid-Triggered Self-Immolative Ketal Glycoside Nanoparticles for Effective Cancer Prodrug Monotherapy. Yu N; Liu T; Zhang X; Gong N; Ji T; Chen J; Liang XJ; Kohane DS; Guo S Nano Lett; 2020 Jul; 20(7):5465-5472. PubMed ID: 32573235 [TBL] [Abstract][Full Text] [Related]
9. Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis. Lorscheider M; Tsapis N; Ur-Rehman M; Gaudin F; Stolfa I; Abreu S; Mura S; Chaminade P; Espeli M; Fattal E J Control Release; 2019 Feb; 296():179-189. PubMed ID: 30659904 [TBL] [Abstract][Full Text] [Related]
10. Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy. Quan LD; Purdue PE; Liu XM; Boska MD; Lele SM; Thiele GM; Mikuls TR; Dou H; Goldring SR; Wang D Arthritis Res Ther; 2010; 12(5):R170. PubMed ID: 20836843 [TBL] [Abstract][Full Text] [Related]
11. Syntheses of click PEG-dexamethasone conjugates for the treatment of rheumatoid arthritis. Liu XM; Quan LD; Tian J; Laquer FC; Ciborowski P; Wang D Biomacromolecules; 2010 Oct; 11(10):2621-8. PubMed ID: 20831200 [TBL] [Abstract][Full Text] [Related]
12. Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis. Libánská A; Randárová E; Skoroplyas S; Bartoš M; Luňáčková J; Lager F; Renault G; Scherman D; Etrych T J Control Release; 2023 Jan; 353():30-41. PubMed ID: 36403682 [TBL] [Abstract][Full Text] [Related]
13. The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse Model. Quan L; Zhang Y; Dusad A; Ren K; Purdue PE; Goldring SR; Wang D Pharm Res; 2016 Jan; 33(1):186-93. PubMed ID: 26286188 [TBL] [Abstract][Full Text] [Related]
14. Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles. Simón-Vázquez R; Tsapis N; Lorscheider M; Rodríguez A; Calleja P; Mousnier L; de Miguel Villegas E; González-Fernández Á; Fattal E Drug Deliv Transl Res; 2022 May; 12(5):1270-1284. PubMed ID: 34993924 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic Acid Coated Acid-Sensitive Nanoparticles for Targeted Therapy of Adjuvant-Induced Arthritis in Rats. Yu C; Li X; Hou Y; Meng X; Wang D; Liu J; Sun F; Li Y Molecules; 2019 Jan; 24(1):. PubMed ID: 30609724 [TBL] [Abstract][Full Text] [Related]
16. Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice. Wei X; Zhao G; Wang X; Gautam N; Jia Z; Zhao Z; Kong D; Zhang F; Kumar S; Sun Y; Chen N; Wang X; Yang L; Ren R; Thiele GM; Bronich TK; O'Dell JR; Alnouti Y; Wang D Nanomedicine; 2020 Oct; 29():102266. PubMed ID: 32679269 [TBL] [Abstract][Full Text] [Related]
17. Cation instructed steroidal prodrug supramolecular hydrogel. Zhou Y; Lei L; Zhang Z; Zhang R; Song Q; Li X J Colloid Interface Sci; 2018 Oct; 528():10-17. PubMed ID: 29803956 [TBL] [Abstract][Full Text] [Related]
18. Dexamethasone-loaded H Lee H; Jeong SW; Jung E; Lee D Nanomedicine; 2020 Nov; 30():102301. PubMed ID: 32942045 [TBL] [Abstract][Full Text] [Related]
19. Dexamethasone Palmitate Encapsulated in Palmitic Acid Modified Human Serum Albumin Nanoparticles for the Treatment of Rheumatoid Arthritis. Zhang Y; Zhou X; Wang Z; Wu M; Zhang W; Zhang Z; Sun X; Gong T J Pharm Sci; 2024 Sep; 113(9):2851-2860. PubMed ID: 39033977 [TBL] [Abstract][Full Text] [Related]
20. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Wang D; Miller SC; Liu XM; Anderson B; Wang XS; Goldring SR Arthritis Res Ther; 2007; 9(1):R2. PubMed ID: 17233911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]